The Association of Rheumatology Professionals (ARP) has developed programming highlighting the perspectives of ...
Results from the phase 3 VOCAL study demonstrate that oral vadadustat dosed 3 times per week successfully maintains hemoglobin levels vs standard ESA therapy in adult hemodialysis patients.
Higher treatment satisfaction, better treatment retention, and fewer adverse events reported for those choosing their treatment.
The sNDA is supported by findings from the phase 3 MANGROVE trial, which demonstrated a 43% reduction in the risk of disease progression or death compared with chemoimmunotherapy in stem cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results